Literature DB >> 8962721

Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs.

G C Hötten1, T Matsumoto, M Kimura, R F Bechtold, R Kron, T Ohara, H Tanaka, Y Satoh, M Okazaki, T Shirai, H Pan, S Kawai, J S Pohl, A Kudo.   

Abstract

We have expressed and biologically characterized recombinant human growth/differentiation factor 5 (huGDF5). This protein is composed of a mature homodimer consisting of 15 kD subunits. Using recombinant expressed protein, we have demonstrated that huGDF5 in vitro stimulated mesenchyme aggregation and chondrogenesis in rat limb bud cells. In vivo, partially purified huGDF5 induced cartilage and bone formation in muscular tissues of rodents. However, in contrast to the effects of other BMPs, as for example BMP-2, the osteoblastic MC3T3-E1 cells did not respond to huGDF5 as measured by alkaline phosphatase activity. These results suggest that the action of GDF5 may be relatively specific for chondrogenesis during the entire process of the endochondral bone formation. GDF5 may control the morphogenesis of cartilaginous tissue, including joints, in the skeletal development of limbs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8962721     DOI: 10.3109/08977199609034567

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  28 in total

Review 1.  Soluble, insoluble and geometric signals sculpt the architecture of mineralized tissues.

Authors:  U Ripamonti
Journal:  J Cell Mol Med       Date:  2004 Apr-Jun       Impact factor: 5.310

2.  Expression of growth differentiation factor-5 and bone morphogenic protein-7 in intraocular osseous metaplasia.

Authors:  S Toyran; A Y Lin; D P Edward
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

Review 3.  Molecular targets for tendon neoformation.

Authors:  Hadi Aslan; Nadav Kimelman-Bleich; Gadi Pelled; Dan Gazit
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

4.  Regional and cellular localisation of BMPs and their inhibitors' expression in human fractures.

Authors:  Francois N K Kwong; Judith A Hoyland; Christopher H Evans; Anthony J Freemont
Journal:  Int Orthop       Date:  2008-11-21       Impact factor: 3.075

Review 5.  The role of growth/differentiation factor 5 (GDF5) in the induction and survival of midbrain dopaminergic neurones: relevance to Parkinson's disease treatment.

Authors:  Aideen M Sullivan; Gerard W O'Keeffe
Journal:  J Anat       Date:  2005-09       Impact factor: 2.610

6.  [Comparison of the osteogenic activity of bone morphogenetic protein (BMP) mutants].

Authors:  R Depprich; J Handschel; W Sebald; N R Kübler; K K Würzler
Journal:  Mund Kiefer Gesichtschir       Date:  2005-11

7.  Isolation of a cDNA sequence of rabbit GDF5 (mature form) and pattern of its mRNA expression during periosteal chondrogenesis.

Authors:  A Sanyal; G Sarkar; J S Fitzsimmons; S W O'Driscoll
Journal:  Mol Biotechnol       Date:  2000-11       Impact factor: 2.695

Review 8.  Control of BMP gene expression by long-range regulatory elements.

Authors:  Steven Pregizer; Douglas P Mortlock
Journal:  Cytokine Growth Factor Rev       Date:  2009-11-08       Impact factor: 7.638

9.  Release of active and depot GDF-5 after adenovirus-mediated overexpression stimulates rabbit and human intervertebral disc cells.

Authors:  Haili Wang; Markus Kroeber; Michael Hanke; Rainer Ries; Carsten Schmid; Wolfgang Poller; Wiltrud Richter
Journal:  J Mol Med (Berl)       Date:  2003-12-11       Impact factor: 4.599

10.  Altered relative expression of BMPs and BMP inhibitors in cartilaginous areas of human fractures progressing towards nonunion.

Authors:  Francois N K Kwong; Judith A Hoyland; Anthony J Freemont; Christopher H Evans
Journal:  J Orthop Res       Date:  2009-06       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.